VRAX

Virax Biolabs Group Limited

HealthcareBiotechnologyGBUSDPeers →Country macro →

$0.17

LiveJun 18, 2026

Market cap

$751.16K

52w range

0.10 – 1.14

P / E

—

EPS

—

Volume

1.03M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Virax Biolabs Group Limited’s valuation

○

Sell-side estimates and price targets skew heavily to US large-caps. We don't have consensus data for this issuer yet.